About this episode

The episode discusses the evolving role of antibody-drug conjugates in the management of various types of breast cancer, featuring insights from multiple experts.

Featuring perspectives from Prof Giuseppe Curigliano, Prof Rebecca A Dent, Dr Erika Hamilton, Prof Nadia Harbeck and Dr Hope S Rugo, moderated by Dr Rugo, including the following topics: Introduction (00:00) Evolving Role of Antibody-Drug Conjugates (ADCs) in the Management of Metastatic Triple-Negative Breast Cancer — Prof Dent (02:57) Integrating ADCs into the Management of HER2-Positive Metastatic Breast Cancer (mBC) — Prof Curigliano (29:01) Role of ADCs in the Management of Endocrine-Resistant Hormone Receptor-Positive mBC — Dr Rugo (52:36) Emerging Utility of ADCs for Localized Breast Cancer — Prof Harbeck (01:14:36) Tolerability Considerations with ADCs for Breast Cancer — Dr Hamilton (01:38:10) CME information and select publications

People in this episode

Host: Dr Hope S Rugo

Guests: Prof Giuseppe Curigliano, Prof Rebecca A Dent, Dr Erika Hamilton, Prof Nadia Harbeck

Topics covered

• Antibody-Drug Conjugates
• Breast Cancer Management
• Metastatic Triple-Negative Breast Cancer
• HER2-Positive Metastatic Breast Cancer
• Endocrine-Resistant Hormone Receptor-Positive Breast Cancer
• Localized Breast Cancer
• Tolerability of ADCs

Keywords

• Antibody-Drug Conjugates
• Breast Cancer
• Metastatic Cancer
• HER2-Positive
• Triple-Negative
• Endocrine-Resistant
• Localized Cancer
• Tolerability

Mentioned in this episode

Organizations: ASCO

More episodes of Breast Cancer Update

• HER2-Positive Metastatic Breast Cancer — An Interview with Prof Dr Sibylle Loibl on First-Line and Maintenance Therapy · July 18, 2026 · 46 min
• Localized HR-Positive Breast Cancer — Year in Review Series on Relevant New Datasets and Advances · July 13, 2026 · 58 min
• For Oncology Nurses: Strategies to Safely and Effectively Implement Antibody-Drug Conjugates — Proceedings from the 2026 Annual ONS Congress · July 10, 2026 · 1h 29m
• HR-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit · June 29, 2026 · 1h 39m
• Metastatic Triple-Negative Breast Cancer — What Clinicians Want to Know · June 26, 2026 · 54 min
• HER2-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit · June 23, 2026 · 52 min

Explore listener stats, chart rankings, contacts and more on the Breast Cancer Update podcast page.